Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 55 articles: HTML format Text format

Single Articles

January 2012
1. RUGBJERG K , Friis S, Lassen CF, Ritz B, et al
   Malignant melanoma, breast cancer and other cancers in patients with parkinson disease.
   Int J Cancer. 2012 Jan 25. doi: 10.1002/ijc.27443.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. MURAKI C , Ohga N, Hida Y, Nishihara H, et al
   Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.
   Int J Cancer. 2012;130:59-70.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. CUST AE , Goumas C, Holland EA, Agha-Hamilton C, et al
   MC1R genotypes and risk of melanoma before age 40 years: A population-based case-control-family study.
   Int J Cancer. 2011 Nov 18. doi: 10.1002/ijc.27357.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
4. IZRAELY S , Sagi-Assif O, Klein A, Meshel T, et al
   The metastatic microenvironment. brain residing melanoma metastasis and dormant micro-metastasis.
   Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27324.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SCHAEFER C , Butterfield LH, Lee S, Kim GG, et al
   Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multi-epitope peptide vaccine trial (ECOG 1696).
   Int J Cancer. 2011 Oct 24. doi: 10.1002/ijc.26481.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. CHATTOPADHYAY C , Ellerhorst JA, Ekmekcioglu S, Greene VR, et al
   Association of activated c-Met with NRAS-mutated human melanomas: A possible avenue for targeting.
   Int J Cancer. 2011 Oct 24. doi: 10.1002/ijc.26487.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. BENDER C , Ullrich A
   PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma cell lines.
   Int J Cancer. 2011 Oct 23. doi: 10.1002/ijc.26486.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
8. CARRETERO R , Wang E, Rodriguez AI, Reinboth J, et al
   Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.
   Int J Cancer. 2011 Sep 30. doi: 10.1002/ijc.26471.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. PICCARD H , Berghmans N, Korpos E, Dillen C, et al
   Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function.
   Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26465.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TANESE K , Grimm EA, Ekmekcioglu S
    The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: Its impact on the chemokine expression profile, including suppression of CXCL10.
    Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26451.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. GIAMMARIOLI AM , Gambardella L, Barbati C, Pietraforte D, et al
    Differential effects of the glycolysis inhibitor 2-deoxy-D-glucose on the activity of pro-apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic response.
    Int J Cancer. 2011 Sep 12. doi: 10.1002/ijc.26420.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. NIELSEN K , Masback A, Olsson H, Ingvar C, et al
    A prospective, population-based study of 40000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma.
    Int J Cancer. 2011 Sep 2. doi: 10.1002/ijc.26408.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. WAN XM , Zheng F, Zhang L, Miao YY, et al
    Autophagy-mediated chemosensitization by cysteamine in cancer cells.
    Int J Cancer. 2011;129:1087-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
14. TAZZYMAN S , Barry ST, Ashton S, Wood P, et al
    Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth.
    Int J Cancer. 2011;129:847-58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ELLIOTT F , Suppa M, Chan M, Leake S, et al
    Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom.
    Int J Cancer. 2011 Aug 5. doi: 10.1002/ijc.26347.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
16. ALCAZAR O , Achberger S, Aldrich W, Hu Z, et al
    Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.
    Int J Cancer. 2011 Jul 27. doi: 10.1002/ijc.26320.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. HATIBOGLU MA , Kong LY, Wei J, Wang Y, et al
    The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.
    Int J Cancer. 2011 Jul 25. doi: 10.1002/ijc.26307.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. MUELLER M , Schlosser E, Gander B, Groettrup M, et al
    Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant.
    Int J Cancer. 2011;129:407-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. SPANGLER B , Kappelmann M, Schittek B, Meierjohann S, et al
    ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma.
    Int J Cancer. 2011 Jul 5. doi: 10.1002/ijc.26277.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
20. LIANG X , Pfeiffer RM, Wheeler W, Maeder D, et al
    Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations.
    Int J Cancer. 2011 Jun 13. doi: 10.1002/ijc.26231.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. TEKLE C , Nygren MK, Chen YW, Dybsjord I, et al
    B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
    Int J Cancer. 2011 Jun 13. doi: 10.1002/ijc.26238.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
22. LUCAS S , van Baren N, de Smet C, Coulie PG, et al
    Demethylation of the FOXP3 gene in human melanoma cells precludes the use of this epigenetic mark for quantification of Tregs in unseparated melanoma samples.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26198.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
23. MIJATOVIC SA , Timotijevic GS, Miljkovic DM, Radovic JM, et al
    Multiple antimelanoma potential of dry olive leaf extract.
    Int J Cancer. 2011;128:1955-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. TROCME E , Mougiakakos D, Johansson CC, All-Eriksson C, et al
    Nuclear HER3 is associated with favourable overall survival in uveal melanoma.
    Int J Cancer. 2011 Apr 11. doi: 10.1002/ijc.26118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
25. YERAMIAN A , Sorolla A, Velasco A, Santacana M, et al
    Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitises melanoma cells to Bortezomib by blocking Akt pathway.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26096.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. FECCHI K , Travaglione S, Spadaro F, Quattrini A, et al
    Human melanoma cells express FGFR/Src/Rho signaling that entails an adhesion-independent caveolin-1 membrane association.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26092.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. PANDEY V , Vijayakumar MV, Ajay AK, Malvi P, et al
    Diet induced obesity increases melanoma progression: Involvement of Cav-1 and FASN.
    Int J Cancer. 2011 Mar 8. doi: 10.1002/ijc.26048.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. ORLOW I , Roy P, Reiner AS, Yoo S, et al
    Vitamin D receptor polymorphisms in patients with cutaneous melanoma.
    Int J Cancer. 2011 Mar 1. doi: 10.1002/ijc.26023.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
29. BAADE P , Meng X, Youlden D, Aitken J, et al
    Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006.
    Int J Cancer. 2011 Feb 22. doi: 10.1002/ijc.25996.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. MOLHOEK KR , Erdag G, Rasamny J, Murphy C, et al
    VEGFR-2 expression in human melanoma: Revised assessment.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25963.
    PubMed     Text format     Related articles   
    
    
    
    
31. ATCHISON EA , Gridley G, Carreon JD, Leitzmann MF, et al
    Risk of cancer in a large cohort of U.S. veterans with diabetes.
    Int J Cancer. 2011;128:635-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
32. MIMURA K , Ando T, Poschke I, Mougiakakos D, et al
    T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2.
    Int J Cancer. 2011;128:390-401.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. MA W , Vigneron N, Chapiro J, Stroobant V, et al
    A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. PAN T , Li X, Jankovic J
    The association between Parkinson's disease and melanoma.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. GAFFAL E , Landsberg J, Bald T, Sporleder A, et al
    Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in Hgf-Cdk4(R24C) C57BL/6 mice.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. ZHANG Q , McCorkle JR, Novak M, Yang M, et al
    Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.
    Int J Cancer. 2011;128:40-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
37. WILLIAMS PF , Olsen CM, Hayward NK, Whiteman DC, et al
    Melanocortin- 1-receptor and risk of cutaneous melanoma: A meta-analysis and estimates of population burden.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
38. MUELLER DW , Bosserhoff AK
    MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. KRETSCHMER L , Starz H, Thoms KM, Satzger I, et al
    Age as a key factor influencing metastasizing patterns and disease-specific survival after sentinel lymph node biopsy for cutaneous melanoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. LEE K , Min HJ, Jang EJ, Hong JH, et al
    In vivo tumor suppression activity by T cell-specific T-bet restoration.
    Int J Cancer. 2010;127:2129-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
41. ROFSTAD EK , Gaustad JV, Egeland TA, Mathiesen B, et al
    Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination.
    Int J Cancer. 2010;127:1535-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
42. OLSEN CM , Zens MS, Green AC, Stukel TA, et al
    Biologic markers of sun exposure and melanoma risk in women: Pooled case-control analysis.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. KUAN CT , Wakiya K, Keir ST, Li J, et al
    Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. SWOBODA RK , Somasundaram R, Caputo L, Berencsi K, et al
    Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient.
    Int J Cancer. 2010;127:1124-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
45. CUST AE , Armstrong BK, Goumas C, Jenkins MA, et al
    Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. RAPPU P , Nylund C, Ristiniemi N, Kulpakko J, et al
    Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. YOUL PH , Baade PD, Parekh S, English D, et al
    Association between melanoma thickness, clinical skin examination, and socioeconomic status: Results of a large population-based study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
48. GALLAGHER RP , Macarthur AC, Lee TK, Weber JP, et al
    Plasma levels of polychlorinated biphenyls (PCB) and risk of cutaneous malignant melanoma: A preliminary study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
49. HEMMINKI K , Ji J, Brandt A, Mousavi SM, et al
    The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies.
    Int J Cancer. 2010;126:2259-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
50. BIRCH-JOHANSEN F , Jensen A, Mortensen L, Olesen AB, et al
    Trends in the incidence of non-melanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. KALLIO J , Hopkins-Donaldson S, Baker AH, Kahari VM, et al
    TIMP-3 promotes apoptosis in non-adherent small cell lung carcinoma cells lacking functional death receptor pathway.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. NUCCITELLI R , Tran K, Sheikh S, Athos B, et al
    Optimized nanosecond pulsed electric field therapy can cause murine malignant melanomas to self-destruct with a single treatment.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
53. OLSEN CM , Carroll HJ, Whiteman DC
    Estimating the attributable fraction for melanoma: A meta-analysis of pigmentary characteristics and freckling.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
54. KHOLMANSKIKH O , van Baren N, Brasseur F, Ottaviani S, et al
    Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte-differentiation antigens.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2009
55. SCATOLINI M , Grand MM, Grosso E, Venesio T, et al
    Altered molecular pathways in melanocytic lesions.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: